BRIEF-IDEAYA Biosciences Announces US FDA IND-Clearance For IDE849, A Potential First-In-Class DLL3 TOP1 ADC, For A Phase 1 Study In Solid Tumors

Reuters
06 May
BRIEF-<a href="https://laohu8.com/S/IDYA">IDEAYA Biosciences</a> Announces US FDA IND-Clearance For IDE849, A Potential First-In-Class DLL3 TOP1 ADC, For A Phase 1 Study In Solid Tumors

May 6 (Reuters) - IDEAYA Biosciences Inc IDYA.O:

  • IDEAYA BIOSCIENCES ANNOUNCES US FDA IND-CLEARANCE FOR IDE849, A POTENTIAL FIRST-IN-CLASS DLL3 TOP1 ADC, FOR A PHASE 1 STUDY IN SOLID TUMORS

  • IDEAYA BIOSCIENCES INC - TO START PHASE 1 STUDY IN U.S. BASED ON FDA GUIDANCE

Source text: ID:nPn1QSZzFa

Further company coverage: IDYA.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10